Redesign of retigabine could improve potency, specificity and side effects of the drug.
Browsing: Epilepsy and seizure
Approval of brivaracetam (BRIVIACT®) as an adjunctive therapy in the treatment of partial-onset seizures in epilepsy patients aged 16 years and older announced by the US-FDA.
This Epigenomics review explores the role of UBE3A in the regulation of protein stability and transcription as well as current understanding of UBE3A imprinting in neurons responsible for the development of a range of neurodevelopmental disorders.
Novel model could assist in personalizing surgical procedures for individuals with epilepsy.
We discuss some of the key research themes that emerged from the American Epilepsy Society’s (AES) Annual Meeting this year.
We get an overview of the results of the perampanel trials from the American Epilepsy Society Annual Meeting (4–8 December 2015, Philadelphia, PA) from Eugen Trinka (Paracelsus Medical University, Salzburg, Austria).
New research highlights the creation of a six-layered 3D printed structure that mimics the structure of brain tissue.
New research in mice has uncovered a potential new approach to the treatment of Rett syndrome, the rare autism spectrum disorder.
This research article evaluates the association between children’s CYP2C9-status and serum valproate concentrations or dose-requirements.